Workflow
Microbix Receives $2.4 Million from Exercise of Warrants
MBXMBX Biosciences, Inc.(MBX) GlobeNewswire·2025-02-04 20:00

Further Capital to Assist with Increasing Capabilities, Capacity, and EfficiencyMISSISSAUGA, Ontario, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it has received C2.4millioninnewequitycapitalfromthepartialexerciseofexpiringsharepurchasewarrants.ThewarrantswereissuedinconnectionwithaprivateplacementundertakeninJanuary,2020,andhadanexercisepriceofC 2.4 million in new equity capital from the partial exercise of expiring share purchase warrants. The warrants were issued in connection with a private placement undertaken in January, 2020, and had an exercise price of C 0.3 ...